Vyome Holdings, Inc SEC filings HIND

Vyome Holdings, Inc has 693 filings in SEC EDGAR's recent list, going back to Feb 13, 2008. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 28, 2026 (officer or director change). The company's fiscal year ends on December 31.

Vyome Holdings, Inc SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Aug 28, 2026 Aug 25, 2026
8-K Current report
Results of operations
Aug 25, 2026 Aug 25, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
May 29, 2026 May 28, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Apr 29, 2026 Apr 24, 2026
DEF 14A Proxy statement Mar 31, 2026 Apr 24, 2026
PRE 14A Preliminary proxy statement Mar 20, 2026 Mar 20, 2026
10-K Annual report Mar 18, 2026 Dec 31, 2025
8-K Current report
Material agreement, Other events
Feb 25, 2026 Feb 20, 2026
8-K Current report
Regulation FD disclosure
Feb 13, 2026 Feb 13, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 28, 2026 Jan 28, 2026
8-K Current report
Material agreement
Dec 23, 2025 Dec 17, 2025
424B3 Prospectus Nov 26, 2025 —
8-K Current report
Results of operations
Nov 19, 2025 Nov 18, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
S-8 Employee stock plan registration Nov 13, 2025 —
S-3 Shelf registration Nov 6, 2025 —
8-K Current report
Shareholder vote results
Oct 30, 2025 Oct 28, 2025
DEF 14A Proxy statement Oct 6, 2025 Oct 28, 2025
8-K Current report
Other events
Oct 3, 2025 Sep 29, 2025
8-K/A Amended current report Sep 12, 2025 Sep 2, 2025
8-K Current report
Other events
Sep 2, 2025 Sep 2, 2025
8-K Current report
Material agreement, Auditor change
Aug 20, 2025 Aug 18, 2025
424B5 Prospectus supplement Aug 20, 2025 —
8-K Current report
Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Aug 19, 2025 Aug 13, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Shareholder vote results
Aug 11, 2025 Aug 7, 2025
425 Filing Jul 30, 2025 —
425 Filing Jul 25, 2025 —
8-K Current report
Shareholder vote results
Jul 25, 2025 Jul 24, 2025
425 Filing Jul 24, 2025 —
425 Filing Jul 24, 2025 —
425 Filing Jul 21, 2025 —
425 Filing Jul 18, 2025 —
425 Filing Jul 15, 2025 —
8-K Current report
Regulation FD disclosure
Jul 15, 2025 Jul 15, 2025
8-K Current report
Material agreement
Jul 3, 2025 Jun 27, 2025
425 Filing Jun 26, 2025 —
424B3 Prospectus Jun 24, 2025 —
EFFECT Filing Jun 20, 2025 —
8-K Current report
Other events
Jun 18, 2025 Jun 18, 2025
POS AM Filing Jun 17, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Jun 12, 2025 Jun 8, 2025
424B5 Prospectus supplement Jun 9, 2025 —
8-K Current report
Other events
Jun 9, 2025 Jun 9, 2025
424B3 Prospectus Jun 6, 2025 —
424B5 Prospectus supplement May 30, 2025 —
8-K Current report
Material agreement
May 30, 2025 May 30, 2025
8-K Current report
Listing notice
May 30, 2025 May 28, 2025
8-K Current report
Other events
May 28, 2025 May 28, 2025
10-Q Quarterly report May 20, 2025 Mar 31, 2025
NT 10-Q Form nt 10-q May 15, 2025 Mar 31, 2025
EFFECT Filing May 14, 2025 —
EFFECT Filing May 14, 2025 —
CORRESP Letter to the SEC May 14, 2025 —
S-4/A Filing May 14, 2025 —
CORRESP Letter to the SEC May 13, 2025 —
S-3 Shelf registration May 9, 2025 —
S-4/A Form s-4/a May 9, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
May 9, 2025 May 6, 2025
UPLOAD Letter from the SEC May 7, 2025 —
DRS Filing May 2, 2025 —
S-4/A Form s-4/a Apr 29, 2025 —
CORRESP Letter to the SEC Apr 28, 2025 —
8-K Current report
Material agreement
Apr 28, 2025 Apr 25, 2025
425 Filing Apr 21, 2025 —
8-K Current report
Material agreement
Apr 21, 2025 Apr 15, 2025
10-K Annual report Apr 4, 2025 Dec 31, 2024
8-K Current report
Shareholder vote results
Apr 2, 2025 Apr 1, 2025
NT 10-K Filing Apr 1, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Mar 20, 2025 Mar 14, 2025
DEF 14A Proxy statement Mar 14, 2025 Apr 1, 2025
UPLOAD Letter from the SEC Mar 14, 2025 —
PRER14A Filing Mar 13, 2025 —
UPLOAD Letter from the SEC Mar 13, 2025 —
PRE 14A Preliminary proxy statement Mar 3, 2025 Mar 3, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Feb 20, 2025 Feb 15, 2025
424B3 Prospectus Feb 18, 2025 —
EFFECT Filing Feb 14, 2025 —
EFFECT Filing Feb 14, 2025 —
S-1MEF Filing Feb 14, 2025 —
424B3 Prospectus Feb 14, 2025 —
S-1/A Amended registration statement Feb 14, 2025 —
CORRESP Letter to the SEC Feb 14, 2025 —
S-1/A Amended registration statement Feb 14, 2025 —
CORRESP Letter to the SEC Feb 13, 2025 —
S-1/A Amended registration statement Feb 13, 2025 —
CORRESP Letter to the SEC Feb 12, 2025 —
UPLOAD Letter from the SEC Feb 12, 2025 —
S-1/A Amended registration statement Feb 7, 2025 —
S-1/A Amended registration statement Feb 6, 2025 —
UPLOAD Letter from the SEC Jan 31, 2025 —
8-K Current report
Material agreement
Jan 21, 2025 Jan 14, 2025
S-1 Registration statement Jan 21, 2025 —
S-4/A Filing Jan 15, 2025 —
S-1/A Amended registration statement Jan 15, 2025 —
CORRESP Letter to the SEC Jan 14, 2025 —
CORRESP Letter to the SEC Jan 14, 2025 —
UPLOAD Letter from the SEC Jan 3, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Dec 27, 2024 Dec 19, 2024
UPLOAD Letter from the SEC Dec 20, 2024 —
S-1 Registration statement Dec 20, 2024 —
425 Filing Dec 11, 2024 —
8-K Current report
Regulation FD disclosure
Dec 11, 2024 Dec 11, 2024
S-4/A Form s-4/a Dec 6, 2024 —
CORRESP Letter to the SEC Dec 5, 2024 —
8-K Current report
Listing notice
Dec 2, 2024 Nov 25, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
UPLOAD Letter from the SEC Nov 1, 2024 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Oct 17, 2024 Oct 16, 2024
S-4 Registration for a merger or exchange Oct 1, 2024 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Sep 24, 2024 Sep 18, 2024
425 Filing Aug 28, 2024 —
425 Filing Aug 28, 2024 —
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
425 Filing Jul 9, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
Jul 9, 2024 Jul 8, 2024
RW Filing Jun 21, 2024 —
8-K Current report
Results of operations
May 20, 2024 May 15, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
S-3 Shelf registration May 9, 2024 —
8-K Current report
Listing notice
Apr 10, 2024 Apr 9, 2024
8-K Current report
Auditor change
Apr 10, 2024 Apr 8, 2024
8-K Current report
Results of operations
Apr 4, 2024 Apr 1, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Shareholder vote results
Feb 26, 2024 Feb 23, 2024
DEF 14A Proxy statement Jan 24, 2024 Feb 23, 2024
8-K Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change
Jan 18, 2024 Jan 11, 2024
PRE 14A Preliminary proxy statement Jan 5, 2024 Jan 5, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Nov 29, 2023 Nov 21, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 8, 2023
8-K Current report
Listing notice
Oct 13, 2023 Oct 10, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Oct 5, 2023 Sep 29, 2023
424B4 Prospectus Oct 3, 2023 —
EFFECT Filing Sep 29, 2023 —
CORRESP Letter to the SEC Sep 28, 2023 —
S-1/A Amended registration statement Sep 27, 2023 —
8-K Current report
Material agreement, Other events
Sep 22, 2023 Sep 19, 2023
S-1/A Amended registration statement Sep 12, 2023 —
UPLOAD Letter from the SEC Aug 30, 2023 —
S-1 Registration statement Aug 25, 2023 —
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 7, 2023 Aug 7, 2023
S-8 Employee stock plan registration Jun 23, 2023 —
8-K Current report
Results of operations
May 16, 2023 May 15, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 26, 2023 Apr 20, 2023
424B5 Prospectus supplement Apr 24, 2023 —
10-K Annual report Apr 17, 2023 Dec 31, 2022
8-K Current report
Restatement
Apr 13, 2023 Apr 7, 2023
NT 10-K Filing Apr 3, 2023 Dec 31, 2022
8-K Current report
Material agreement
Mar 21, 2023 Mar 13, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Feb 10, 2023 Feb 6, 2023
424B4 Prospectus Feb 8, 2023 —
EFFECT Filing Feb 3, 2023 —
S-1MEF Filing Feb 3, 2023 —
CORRESP Letter to the SEC Feb 3, 2023 —
CORRESP Letter to the SEC Feb 3, 2023 —
S-1/A Amended registration statement Feb 3, 2023 —
RW WD Filing Feb 3, 2023 —
RW Filing Feb 2, 2023 —
RW Filing Feb 2, 2023 —
S-1/A Amended registration statement Feb 2, 2023 —
CORRESP Letter to the SEC Feb 1, 2023 —
CORRESP Letter to the SEC Feb 1, 2023 —
8-K Current report
Other events
Jan 27, 2023 Jan 26, 2023
S-1/A Amended registration statement Jan 27, 2023 —
UPLOAD Letter from the SEC Jan 20, 2023 —
S-1 Registration statement Jan 12, 2023 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Dec 28, 2022 Dec 21, 2022
8-K Current report
Officer or director change, Shareholder vote results
Dec 20, 2022 Dec 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Nov 14, 2022 Nov 8, 2022
DEF 14A Proxy statement Nov 10, 2022 Dec 14, 2022
424B5 Prospectus supplement Nov 9, 2022 —
PRE 14A Preliminary proxy statement Oct 31, 2022 Dec 14, 2022
10-Q Quarterly report Aug 19, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 16, 2022 Aug 15, 2022
NT 10-Q Filing Aug 16, 2022 Jun 30, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 2, 2022 Jul 27, 2022
8-K Current report
Listing notice, Regulation FD disclosure
Jul 25, 2022 Jul 19, 2022
8-K Current report
Auditor change
Jul 21, 2022 Jul 15, 2022
8-K Current report
Material agreement, Unregistered share sale
Jun 23, 2022 Jun 16, 2022
10-Q Quarterly report May 23, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 23, 2022 May 23, 2022
NT 10-Q Filing May 13, 2022 Mar 31, 2022
8-K Current report
Auditor change
Apr 14, 2022 Apr 8, 2022
10-K Annual report Apr 8, 2022 Dec 31, 2021
NT 10-K Filing Apr 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 28, 2022 Mar 28, 2022
8-K/A Amended current report
Results of operations
Mar 22, 2022 Mar 17, 2022
8-K Current report
Results of operations
Mar 17, 2022 Mar 17, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 12, 2021 Nov 11, 2021
424B3 Prospectus Sep 21, 2021 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HIND (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Clemente, CA
SEC filer status
, Emerging growth company
SEC CIK
1427570
Former names
ReShape Lifesciences Inc. (until Aug 14, 2025); OBALON THERAPEUTICS INC (until Jun 21, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.